Diabetic Ketoacidosis: Systematic Review and Meta‐Analysis
Open Access
- 9 November 2026
- journal article
- review article
- Published by Wiley in Diabetes, Obesity and Metabolism
Abstract
Aims: Diabetic ketoacidosis (DKA) remains a major cause of diabetes‐related morbidity and mortality worldwide, yet evidence on its management and clinical outcomes across healthcare settings remains limited. We conducted a systematic review and meta‐analysis to evaluate the precipitants, management and outcomes of adult DKA. Materials and Methods: We searched PubMed, Embase, Web of Science, Scopus, MEDLINE, CINAHL and ERIC from 2000 to April 2026 for studies reporting precipitating factors, management and outcomes among adults (≥ 16 years) with DKA. Articles that did not report all three were excluded. Two reviewers independently screened studies, extracted data and assessed risk of bias. Descriptive synthesis was performed for demographic, biochemical, management and outcome variables. A random‐effects meta‐analysis estimated summary in‐hospital all‐cause mortality. This review was registered with PROSPERO (ID: CRD42025641665). https://www.crd.york.ac.uk/PROSPERO/view/CRD42025641665 . Results: Nineteen studies met the inclusion criteria, of which 15 studies comprising 1278 DKA episodes contributed to the descriptive synthesis and nine studies including 724 participants to the mortality meta‐analysis. Most episodes were classified as moderate or severe DKA. Preadmission glycaemic control was frequently suboptimal. Missed or inadequate diabetes medication was the commonest precipitant (42.2%), followed by infection (28.6%) and newly diagnosed diabetes (11.2%). Substantial regional variation was observed in guideline use, insulin and fluid administration, intensive care admission and treatment‐related complications. The in‐hospital mortality summary estimate was 2.17% (95% CI, 0.93%–4.99%). Conclusion: Medication omission and infection remain the dominant precipitants of adult DKA worldwide. Marked variation in management practices and outcomes persists across healthcare systems, suggesting inconsistent implementation of DKA care pathways.Keywords
Funding Information
- National Institute for Health and Care Research (NIHR303671)
This publication has 20 references indexed in Scilit:
- Effectiveness and Safety of Early Insulin Glargine U100 and Glargine U300 Administration in the Management of Diabetic Ketoacidosis in Adults With Type 1 Diabetes Mellitus: A Randomized Clinical TrialEndocrine Practice, 2025
- Guidelines for the management of diabetes‐related ketoacidosis (DKA) have been poorly adopted and implemented, resulting in a lack of improvement in outcomesDiabetic Medicine, 2025
- Health system capacity to manage diabetic ketoacidosis in nine low-income and lower-middle income countries: a cross-sectional analysis of nationally representative survey dataeClinicalMedicine, 2022
- Meta‐analysis of prevalence: I2 statistic and how to deal with heterogeneityResearch Synthesis Methods, 2022
- A 10‐year audit of pregnancies affected by diabetic ketoacidosis at the Pretoria Academic ComplexInternational Journal of Gynecology & Obstetrics, 2022
- Flash Glucose Monitoring Compared to Capillary Glucose Levels in Patients With Diabetic Ketoacidosis: Potential Clinical ApplicationsEndocrine Practice, 2021
- Clinical Effects of Balanced Crystalloids vs Saline in Adults With Diabetic KetoacidosisJAMA Network Open, 2020
- First-time Diabetic Ketoacidosis in Type 2 Diabetics With Covid-19 Infection: A Novel Case SeriesThe Journal of Emergency Medicine, 2020
- Use of a standardised diabetic ketoacidosis management protocol improved clinical outcomesDiabetes Research and Clinical Practice, 2014
- Predictors of intensive care unit and hospital length of stay in diabetic ketoacidosisJournal of Critical Care, 2002